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Abstract: The complete synthesis, optimization, purification, functionalization and evaluation
of vertically aligned multiwalled carbon nanotubes (VA-MWCNTs) was reported for potential
application in dexamethasone delivery to the ischemic brain tissue. The conditions for high yield
were optimized and carbon nanotubes functionalized and PEGylated prior to dexamethasone loading.
Morphological changes were confirmed by SEM and TEM. Addition of functional groups to MWCNTs
was demonstrated by FTIR. Thermal stability reduced following MWCNTs functionalization as
demonstrated in TGA. The presence of carbon at 2θ of 25◦ and iron at 2θ of 45◦ in MWCNTs
was illustrated by XRD. Polydispersive index and zeta potential were found to be 0.261 and
−15.0 mV, respectively. Dexamethasone release increased by 55%, 65% and 95% in pH of 7.4, 6.5 and
5.5 respectively as evaluated by UV-VIS. The functionalized VA-MWCNTs were demonstrated to be
less toxic in PC-12 cells in the concentration range from 20 to 20,000 µg/mL. These findings have
demonstrated the potential of VA-MWCNTs in the enhancement of fast and prolonged release of
dexamethasone which could lead to the effective treatment of ischemic stroke. More work is under
way for targeting ischemic sites using atrial natriuretic peptide antibody in stroke rats.
Keywords: multiwalled carbon nanotubes; chemical functionalization; chemical vapor deposition;
PEGylation; ischemic stroke article; yet reasonably common within the subject discipline
1. Introduction
Carbon nanotube synthesis and their application in various fields have become more popular
to date. Carbon nanotubes (CNTs) are a fairly new group of nanomaterials that have demonstrated
promising results in various areas of nanomedicine due to their unique structures and outstanding
physicochemical properties [1]. Based on their unique properties, CNTs have attracted much attention
since a report by Iijima in 1991 [2]. CNTs are potential candidates for a variety of applications such
as chemical sensors, nanoelectronics, catalyst support, targeting of diseased sites and drug delivery
systems. The nature and quality of CNTs are highly dependent on the method of synthesis which
regulates the graphitization degree, helicity and diameter [3].
A spectrum of procedures to produce CNTs have been reported, and the most commonly used
procedures are arc discharge, laser ablation and chemical vapor deposition. The catalytic chemical
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vapor deposition (CCVD) is the most popular and preferred technique for the production of MWCNTs
in large scale as it is inexpensive and can produce high quality MWCNTs [4]. Nebulized spray pyrolysis
is an improved version of CVD method with the ultra-high frequency radiation used to nebulize
reactants in solution to produce a reactant aerosol. The aerosol is carried into a high temperature
furnace by a suitable carrier gas. The reaction is achieved by placing the reaction mixture in a reservoir
with a piezo electric transducer at the base and then connected to a frequency generator [5]. CVD is
divided into a floating catalyst method in which a catalyst is in a gas phase and a fixed catalyst method
in which a catalyst is supported in a solid phase. In the floating catalyst method, there is no need
for catalyst preparation as the catalyst particles are continuously formed [6]. A precursor, ferrocene,
is dissolved in organic solvent which also serves as a carbon source. It is based on the hydrocarbon
decomposition on metallic catalysts such as iron, nickel, cobalt and molybdenum [7].
Dexamethasone is a glucocorticoid with anti-inflammatory properties rendering it potentially
effective for the treatment of inflammatory diseases including ischemic stroke. However, its therapeutic
potential is negatively affected by the short circulatory half-life and poor pharmacokinetics requiring
administration of higher doses which could lead to serious systemic side-effects [8]. In addition,
dexamethasone could also cause hemorrhage and edema in stroke patients. If low doses of
dexamethasone are conjugated to MWCNTs and targeted to the diseased site by a specific antibody,
the current drawbacks may be overcome. Functionalization of these MWCNTs may increase
biocompatibility, appendability of the drug to CNTs, and permeability of drug to cells and decrease
the cytotoxicity of the CNTs.
In this study, the effect of various factors such as synthesis temperature, synthesis duration, gas flow
rate, catalyst and location of silicon wafer in the furnace influencing the quality and yield of MWCNTs is
investigated. For dexamethasone release studies, MWCNTs were first functionalized with acids, acylated,
amidated and PEGylated prior to loading dexamethasone. The toxicity of the functionalized carbon
nanotubes was evaluated using PC12 cells. Dexamethasone 21 phosphate was successfully loaded onto
and released from the PEGylated VA-MWCNTs for the first time. These findings have demonstrated that
VA-MWCNTs have a potentially important role in the fast and prolonged release of dexamethasone which
could lead to an effective treatment of ischemic stroke. More work is under way for targeting ischemic
sites using atrial natriuretic peptide antibody in stroke rats.
2. Results and Discussion
2.1. Location of the Substrate, Catalyst Concentration and Acid Purifiction of MWCNTs
The location of the substrate, synthesis temperature, catalyst concentration, synthesis duration,
argon flow rate were varied to determine the optimal pyrolysis conditions for the growth of MWCNTs.
Aligned MWCNTs were successfully grown on the silicon wafer when it was placed 14 cm from
the furnace inlet (Figure 1A,D,F). Carbon nanospheres and graphitic flakes were obtained when Si
substrates were placed at the furnace centre (Figure 1B,C). MWCNTs consisting of more than one
wall and iron nanoparticles were observed in their cavities (Figure 1E) and well aligned MWCNTs
were obtained when temperatures of 850 ◦C and 775 ◦C were used (Figure 1A,F) whereas higher
temperatures around 900 ◦C led to the formation of carbon flakes and nanospheres (Figure 1B,C).
Temperatures of 775 ◦C and 850 ◦C were found to be the optimal temperatures for iron atom
mobility to form catalytic particles and toluene decomposition to form carbon and nucleate MWCNTs.
At temperatures below 750 ◦C, the iron atoms were not mobile enough to aggregate together into
particles to nucleate and grow nanotubes. At temperatures above 850 ◦C, the catalyst becomes highly
mobile and quickly agglomerates into metal particles that are too large to initiate carbon nanotube
nucleation, resulting in a process called ‘carbon overcoating’ [9] which results in the formation of
carbon nanospheres and flake-like structures (Figure 1B,C).
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Figure 1. Vertically aligned multiwalled carbon nanotubes (MWCNTs) collected from silicon wafer
14 cm from the furnace inlet at 850 ◦C (A); Carbon nanospheres produced at 900◦C (B); Carbon flakes
from the furnace centre at 900 ◦C (C); MWCNTs from quartz tube walls at 850 ◦C (D); TEM micrograph
of aligned MWCNTs (E) with magnified MWCNT insert. MWCNTs grown at 775 ◦C (F).
Composition and concentration of the catalyst are important in MWCNT synthesis. A lower
concentration leads to SWCNT formation, while a higher concentration leads to MWNT formation [10].
Different concentrations of ferrocene in toluene (25, 50 and 100 mg/mL) was used to evaluate the effect
of the content of transition metal on the growth of MWCNTs. The thickness of MWCNTs increased
with an increase in the ferrocene content. When 25 mg/mL of catalyst was used, MWCNTs with clean
surfaces were produced with less or no iron nanoparticle layers on their surfaces (Figure 2A–C).
Ghaharpour and colleagues have demonstrated in their work that the higher content of catalysts
provided better conditions for the growth of carbon nanotubes [11]. In this study, a higher concentration
of catalyst (100 mg/mL) produced a thick layer of iron nanoparticles on the surface of MWCNTs
(Figure 2A), whereas a thin layer was noticed when 50 mg/mL ferrocene was used (Figure 2B).
There was no formation of iron nanoparticle layer when 25 mg/mL ferrocene was used as a catalyst
(Figure 2C). Furthermore, acid purification eliminated the contaminants such as amorphous carbon
and iron nanoparticles from carbon nanotubes.
VA-MWCNTs were treated with different acids for purification to remove amorphous carbon and
residual iron. In addition, the treatment was performed to increase the dispersibility and hydrophilicity
of the MWCNTs. When MWCNTs were subjected to HNO3:H2SO4 (1:3), holes with mean diameter
of 104.31 µm were formed on MWCNTs (Figure 2D). A mixture of HNO3 and H2SO4 oxidized the
iron nanoparticle, amorphous carbon and MWCNTs, leading to the formation of holes on MWCNTs.
When MWCNTs were exposed to 5 M HCl, honeycomb-like structures with a mean diameter of 12.30 µm
were generated (Figure 2E). Concentrated HCl resulted in the oxidation of MWCNTs leading to the
formation of holes with mean diameter of 85.82 µm and shrinking on the surface of MWCNTs (Figure 2F).
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Figure 2. MWCNTs at various catalyst concentrations and purified with different acids.
MWCNTs synthesised in 100 mg/mL ferrocene (A); MWCNTs prepared in 50 mg/mL ferrocene
(B); MWCNTs when 25 mg/mL ferrocene was used (C). MWCNTs treated with different acids namely
concentrated H2SO4:HNO3 (3:1) (D); 5 M HCl (E) and concentrated HCl (F).
2.2. Determination of Crystallinity, Thermal Properties and Raman Spectroscopy of MWCNTs
Two characteristic peaks were observed at the angle (2θ) of 25◦ and 45◦, confirming the presence
of carbon in MWCNTs and iron in ferrocene, respectively (Figure 3A).
Thermal stability and purity of MWCNTs were determined using a thermogravimetric analyser.
While the TGA curve of the pristine MWNTs showed no significant mass loss up to 600 ◦C, one sharp
mass loss for the functionalized samples was observed in the temperature range from 150 to 775 ◦C.
The sharp mass loss observed in the temperature range of the functionalized samples could be
attributed to the HCl on the MWNTs surface, unreacted carboxylic acid groups as well as MWNTs that
were oxidized in carboxylation stage (Figure 3B).
Acid functionalized MWNTs showed the remaining weight to be around 3% at 775 ◦C, which is
attributed to the metal catalyst or the ash of MWNTs. Pristine MWNTs showed the remaining weight
to be ~8% at 825 ◦C. Significant weight loss started at 150 ◦C and 600 ◦C in acid functionalized and
pristine MWCNTs, respectively (Figure 3B). Complete decomposition occurred at 725 ◦C and 825 ◦C in
acid functionalized and pristine MWCNTs, respectively. The findings confirm a successful purification
of MWCNTs as depicted by fewer remains in the functionalized MWCNTs as opposed to impure
pristine MWCNTs.
MWCNTs were PEGylated and their Raman spectra determined by Raman Micro200
(Perkin Elmer, Waltham, MA, USA). The D and G bands were observed in the non-PEGylated MWCNTs
at 1310 cm−1 and 1586 cm−1, respectively (Figure 3C). A shift of both the D and G bands to the right
was observed when MWCNTs were functionalized with PEG and dexamethasone as compared to
the non-PEGylated CNTs (Figure 3D). There was a significant rise in the D band intensity and a drop
in the G band intensity following functionalization. Our data agree with the work done by Voge
and colleagues as they also observed a shift of D and G bands to the right in the functionalized
MWCNTs [12]. Loading of dexamethasone caused a drastic decrease in the intensities of both bands
and this could be due to the linkage that occurred between the PEGylated CNTs and dexamethasone.
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Figure 3. XRD diffraction pattern, TGA and Raman spectra of MWCNTs. Diffraction pattern of pristine
MWCNTs (A); TGA of both pristine and HCl-treated MWCNTs (B); Raman spectrum of pristine
MWCNTs (C) and Dex and PEG-CNTs (D).
2.3. Effect of Synthesis Times and Gas Flow Rates on the Length and Diameter of MWCNTs
When different reaction times were employed in the synthesis of MWCNTs, a linear relationship
was noticed between reaction time, length and external diameter of carbon nanotubes as demonstrated in
Figure 4A,B. An increased catalyst annealing duration led to higher concentration of iron nanodroplets
which enabled faster diffusion of carbon leading to more vertically aligned carbon nanotubes and higher
growth efficiency. Rahman and colleagues synthesized aligned SWCNTs using annealing times of 10 s,
3 min, 10 min and 15 min. They found that the height of the SWCNT array increased from 229 µm to
246.5 µm as the catalyst annealing time was increased from 3 min to 10 min [7].
In this study, various flow rates of argon ranging from 400 to 600 mL/min were used and
a linear relationship (R2 = 0.99711) between the gas flow rate and thickness was observed (Figure 4D).
The carrier gas flow rate influenced the distribution of the carbonaceous products on the quartz tube
walls and substrate. Tewari and Sharma investigated the effect of carrier gas flow rates of argon,
nitrogen and ammonia on the yield of carbon nanotubes and found that there was a direct relationship
between the flow rate and the yield of carbon nanotubes [6]. In this study, 95% argon balanced with 5%
hydrogen was used to produce quality carbon nanotubes. There was no effect on the internal diameter
of the MWCNTs as the synthesis time and gas flow rate were increased (Figure 4B,C). In this work,
iron nanoparticles of 10 nm in diameter was used and the MWCNTs produced were of the internal
diameter of around 10 nm. The internal diameter of MWCNTs remained constant as it was restricted
by the size of iron nanoparticles.
As the synthesis time increased, the walls on the MWCNTs increased in number leading to an
increase in external diameter (Figure 4B) as the external diameter is entirely dependent on the growth
period of the carbon nanotubes. The external diameter decreased with an increase in the carrier gas
flow rate as a result of carrier gas molecules occupying the catalyst sites to a greater degree than
toluene molecules. Khorrami and Lotfi reported that an increase in the carrier gas flow rates decreased
the formation of MWCNTs, because carrier gas molecules occupied catalyst sites more than ethanol
molecules leading to the reduction of external diameter of the MWCNTs [13]. In this study, the external
diameter dropped with a rise in gas flow rate as demonstrated in Figure 4C.
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Figure 4. Synthesis parameters of MWCNTs. Synthesis time on the length or thickness of MWCNTs on
both the silicon wafer (black column) and the reactor tube walls (red column) (A); synthesis time on
both the MWCNTs internal (red column) and external (green column) diameters (B); carrier gas flow
rate on both the MWCNTs internal (red column) and external (green column) diameters (C); carrier gas
flow rate on MWCNTs length on both silicon wafer (red column) and reactor wall (green column) (D).
2.4. Mixture of Ferrocene/Nickelocene/Cobaltocene on MWCNT Growth
Bimetallic nanoparticles are more reliable catalysts than single element catalysts because both
metals in the bimetallic nanoparticles can enhance certain functions by playing complementary catalytic
roles [14]. The yield of CNTs increases many folds in comparison to using monometallic catalysts.
It has been found that, whilst all the metals are able to produce CNTs, iron catalysts gave a large
yield. The superior performance of the iron catalyst was attributed to iron higher carbon solubility,
which helps to promote the production of CNTs [15]. In this study, a combination of ferrocene and
cobaltocene resulted in higher total yield of MWCNTs than ferrocene alone and a mixture of both
ferrocene and nickelocene. When a trimetallic catalyst was used, there was a slight reduction in the
yield but still higher than ferrocene alone (Table 1).
Table 1. MWNT production using a combination of various catalysts.
Catalyst Location Mass before Run (g) Mass after Run (g) Final Mass (g) Total Mass (g) Yield %
Fe 25 mg/mL Wafer 0.1114 0.1222 0.0108 0.1879 –QT – 0.1771 0.1771
Fe 25 mg/mL
Ni 1.25 mg/mL
Wafer 0.1278 0.1282 0.0004
0.3312 43.27QT - 0.3312 0.3312
Fe 25 mg/mL
Co 1.25 mg/mL
Wafer 0.0933 0.0935 0.0002




Wafer 0.0435 0.0454 0.0019
0.2733 31.25




Wafer 0.1476 0.1481 0.0005
0.5097 63.14
QT – 0.5092 0.5092
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2.5. Porositometric and Particle Size Distribution Properties of MWCNTs
Following functionalization of CNTs with H2SO4, surface characteristics of both the pristine and
functionalized MWCNTs were determined by a surface area and porosity analyser. BET measurements
of MWCNTs are summarized in Table 2 and isotherms are demonstrated in Figure 5A. These isotherm
plots display the Type IV adsorption as there is formation of monolayers by capillary condensation
on mesoporous surfaces of the CNTs. The black and green curves indicate the adsorption of liquid
nitrogen and the red and blue curves indicate desorption of liquid nitrogen from the CNTs. The pristine
and H2SO4 functionalized MWCNTs were found to be mesoporous according to IUPAC based on their
pore size range of 13 to 18 nm.
Table 2. Surface area of pristine and 5 M HCl functionalized MWCNTs.
Type BET Surface Area (m2/g) Pore Size (nm) Pore Volume (m3/g)
Pristine MWCNTs 47.1563 13.08973 0.154316
5 M HCl-MWCNTs 144.0962 18.08957 0.651660
% Increase 67.27 27.64 76.32
Acid treatment improved MWCNTs surface area as demonstrated by Figure 5A. Acid treatment
increased the surface area, pore size and pore volume of the MWCNTs by 67.27%, 27.64% and 76.32%,
respectively as depicted in Table 2.
CNTs are hydrophobic in nature and their dispersibility is achieved by functionalization by
attachment of polar groups such as carbonyl (–C(O)–), carboxyl (–COOH), and hydroxyl (–OH) [16].
The data obtained confirmed the hydrophobic nature of the pristine MWCNTs and hydrophilic
nature of the H2SO4 functionalized MWCNTs.
A Zetananosizer ZS (Malvern Instruments, Worcestershire, UK) was used to determine particle
size distribution and zeta potential of MWCNTs. Zhao and colleagues demonstrated that defects in
MWCNTs were more likely to form and functional groups were successfully grafted onto MWCNTs
after oxidation. They also showed that the functionalized MWCNTs with negative groups as observed
in Zeta potential measurements had superior suspension stability and could remain as a colloidal
solution for 30 days [17]. In this study, the H2SO4 functionalized MWCNTs were suspended in
deionized water at a concentration of 0.2 mg/mL and particle size distributions and zeta potentials
were measured. The Z-average diameter and polydispersity index (PDI) were 287.08 nm and 0.261,
respectively. This PDI indicates that the MWCNTs have a moderate size distribution. The zeta
potential and conductivity were −15.0 mV and 0.0213 mS·cm−1 respectively. The MWCNTs possess
negative charge on their surface and the zeta potential magnitude of 15 implies that the MWCNTs are
slightly agglomerated.
Nanoparticles possess properties that depend entirely on their dimensions. There is currently
a plethora of methods for surface characterization of nanoparticles. The PSD values of the MWCNTs are
different from SEM and TEM values as the techniques operate differently to measure the dimensions of
the particles (Figure 5B). For particle size distribution (DLS), the particles are suspended in a solution
and the measurements are performed while the particles are in solution based on Brownian motion.
The individual particles may agglomerate leading to an increase in the hydrodynamic diameter.
In SEM, the particle is in a solid state (dry condition) and the length of the individual particle
could be determined easily. For TEM, the particle is also in a solid state and the length of the particle
could be determined depending on the size (if too long, this could be determined by SEM). In TEM,
the internal and external diameters could be determined as this technique has a better resolution
compared to SEM. In general, SEM is suitable for large particles (above 50 nm in diameter) while
TEM offers accurate results in small particles. DLS is a suitable technique for particles in solutions but
inappropriate for polydispersive and heterogenous samples [18].
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Figure 5. Porositometric and particle size properties of MWCNTs. BET isotherms for both the pristine
(black curve for N2 adsorption and red curve for desorption) and HCl-treated (green curve for N2
adsorption and blue curve for desorption) MWCNTs (A). Particle size distribution of pristine and
H2SO4-treated (for improving dispersibility and hydrophilicity) carbon nanotubes (B).
2.6. FTIR Spectroscopy and H1 NMR Analyses of PEGylated MWCNTs
Relative to the spectrum for pristine MWCNTs, Figure 6A, the intensity of O-H and C-H stretching
bands increased and broadened in the spectrum of MWCNTs-HCl, Figure 6A, due to acid treatment
peaks that were observed at 1638 cm−1 which could be ascribed to C=C, respectively, in both the
pristine and functionalized MWCNTs. [7].
In the 1H-NMR spectrum of PEG-CNTS (Figure 6B) there are chemical shifts observed only at δ
3.69 and 3.36 ppm which can be ascribed to the methylene protons on the PEG backbone [19]. The other
proton signals were too weak and therefore not observed due to limited solubility of the PEG-CNTS
in methanol. Relative to the spectrum of PEG-CNTS (Figure 6B) there are several new signals in the
spectrum of Dexamethsone-21-phosphate loaded-PEG CNTS (Figure 6B) due to the presence of the
loaded drug. For example, the presence of downfield protons 6.26 ppm (C=C-H) and 6.43 ppm are
indicative of the steroid ring A system.
Relative to the spectrum of Dexamethsone-21-phosphate (Figure 6B) there are similar chemical
shifts observed in the spectrum of Dexamethasone-21-phosphate loaded-PEG CNTS (Figure 6B).
Furthermore, these signals show no significant shifts. Chemical shift at 3.75 ppm represents methylene
protons on the PEG backbone (Figure 6B) and confirm the presence of the CNTs. Therefore, based on
the 1H-NMR observations it can be proposed that the drug has being loaded into the CNT carrier
(Scheme 1). The proposed loading sites and mechanism of loading that the drug is present in the
formulation, where it may reside on the surface, inside the cavity of the tube or possible covalent
interactions may occur as there are some (4.94, 4.64 ppm) slight upfield shifts (4.93, 4.61 ppm) [20].
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Figure 6. Molecular spectral properties of pristine and functionalized MWCNTs. FTIR spectra
of pristine (red spectrum) and HCl functionalised (black spectrum) MWCNTs (A); 1H-NMR spectra
of PEG-CNTs, Dexamethasone, and Dex-PEG-CNTs (B).
2.7. Dexamethasone Loading to and Release from MWCNTs
Pristine MWCNTs are limited in drug delivery systems due to their poor drug entrapment
capability [21]. The successful entrapment of dexamethasone was reported which is enabled due to
the novel functionalization carried out. PEG-MWCNTs and non-PEG-MWCNTs were tested using
dexamethasone-21-disodium phosphate because of the increased solubility of the phosphate derivative.
Dialysis tubing over 12 h at various time intervals indicated the initial release of dexamethasone
from MWCNTs after 0.5 h in PBS buffer with pH 5.5 and pH 7.4 in non-PEGylated MWCNTs.
Maximum dexamethasone release occurred after 2 h and 6 h following dialysis in an basic and
acidic milieu, respectively, and remained constant up to 12 h in PEGylated MWCNTs (Figure 7A).
A change in the release pattern of dexamethasone from MWCNTs was observed in the PEGylated
MWCNTs (Figure 7B). An initial gradual release of dexamethasone occurred after 0.5 h following
dialysis in all PBS buffers. Maximum dexamethasone release was observed after 2 h in pH 7.4 PBS
buffer 6 h in both pH 6.5 and 5.5 and remained constant thereafter. Only 55% of dexamethasone loaded
on non-PEGylated MWCNTs were released in PBS buffer with pH 7.4 and 70% released in a buffer
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with pH of 5.5 (Figure 7A). Venditti and colleagues, in their work, loaded dexamethasone on gold
nanoparticles and only 70% of the loaded drug was released in 5 days [22]. Roozbahani and colleagues
studied dexamethasone release from laponite nanoplates. In their work, 47% of dexamethasone was
released at pH = 7.4 while 76% was released at pH = 5.4 after 3 days [23].
In our study, a fast release with more than 50% was observed after 4 h. Drug remained entrapped
due to weak interaction in CNT cavities and cannot achieve 100% release as a result.
Dexamethasone release was notably improved in PEGylated MWCNTs with 55%, 65%, 95% release
in PBS buffers with pH 7.4, 6.5 and 5.5, respectively (Figure 7B), as compared to non-PEGylated
MWCNT. It is possible that the slow release observed in Figure 7B is due to the ionic interaction
between the opened charged MWCNTs and dexamethasone [24].
There are two possible mechanisms that could have taken place: namely drug loading as a result
of entrapment into the inner cavities of the carbon nanotubes and ionic interaction as a result of
phosphate derivative. The mechanisms of dexamethasone release from PEGylated MWCNTs in acidic
and basic milieu have been demonstrated to be different.
Figure 7. Dexamethasone release curves. Dex-MWCNTs in PBS buffer with pH 7.4 and pH 5.5 (A);
Dex-PEG-MWCNTs in PBS buffer with pH 7.4, pH 6.5 and pH 5.5 (B).
The burst and subsequent sustained release could play a vital role in the therapeutic treatments,
as the initial fast release could rapidly afford a therapeutic dose, and the succeeding sustained release
could preserve the therapeutic dose for a prolonged period. The above findings have demonstrated an
improved sustained release of dexamethasone when loaded to the PEGylated MWCNTs.
2.8. Cytotoxicity Evaluation of the Functionalized Carbon Nanotubes
Pristine carbon nanotubes are toxic, but their toxicities are reduced when they undergo
functionalization. PC-12 cell lines were successfully grown in RPMI 1640 medium (Figure 7) and incubated
with various concentrations of dexamethasone and functionalized carbon nanotubes for 24 h.
Zeinabad and colleagues studied the effects of SWCNTs and MWCNTs in PC-12 cells using
concentrations ranging from 0.01 to 100 µg/mL. SWCNTs induced higher in vitro cytotoxicity against
PC-12 as compared to MWCNTs as demonstrated by MTT assay. A decline in cell viability was
observed as the concentration of the carbon nanotubes was increased [25].
Gopinathan and colleagues developed poly(ε-caprolactone)-based nanocomposite (PCL) scaffolds
and evaluated their toxicity in PC-12 cells using a Cytox 96 cytotoxicity assay kit. Cell viability
analyses demonstrated that there was no cell death within 48 h of incubation of PC-12 cells
with the PCL nanocomposites [26]. In our study, PC-12 cells were seeded in 96 well plate at
a concentration of 6× 104 cells/mL/well and incubated with various concentrations of dexamethasone
and functionalized carbon nanotubes ranging from 20 to 20,000 µg/mL.
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The average diameter of the cells was found to be approximately 50 µm as depicted in Figure 8.
Cell viability was reduced from 100% to approximately 90% as demonstrated in Figure 8. The 10%
decrease in viability demonstrated the very low cytotoxic effect of the functionalized carbon nanotubes.
Therefore, these functionalized carbon nanotubes could be utilized as nanocarriers of anti-inflammatory
drugs such as dexamethasone at a very low dose to the ischemic site in the stroke patient leading to
the effective treatment of stroke.
Figure 8. Cell viability following incubation with various concentrations of functionalized
carbon nanotubes. H2SO4-MWCNTs were used as they are highly dispersible and hydrophilic.
Blue column = free dexamethasone, brown column = equivalent dexamethasone concentration coupled
to PEGylated MWCNTs and grey column for sulfonitric acid functionalized MWCNTs without
dexamethasone. Concentrations of each formulation expressed as µg/mL from 0 to 20,000.
3. Materials and Methods
3.1. Synthesis of MWCNTs Using Chemical Vapor Deposition
A circular silicon wafer (single side polished, <100>, N-type, contains No dopant, diam. × thickness
2 in. × 0.5 mm) from Sigma-Aldrich Corporation (St Louis, MO, USA) was dissected into 1 cm × 1 cm
pieces and sonicated in acetone, methanol and water for 5 min. The silicon wafer was loaded into the quartz
reactor tube to act as a platform for MWCNTs growth. The quartz tube was then inserted in a horizontal
high temperature tube furnace (Elite TSH 12/38/500-2216E, Leicestershire, UK). The reaction vessel was
activated with 40 mL catalyst and 95% baseline argon balanced with 5% hydrogen was used as a carrier gas.
Flow rate was set to 50 mL/min to create an inert environment using mass flow controller (D08-4D/ZM,
Beijing Sevenstar, Huachuang Electronic Co., Ltd., Beijing, China). The nebulizer (Dr Hielscher UM20-1.6
MHz Sonic, Teltow, Germany) was used to generate an aerosol. The temperature was set to 775 ◦C at
a ramp of 10 ◦C·min−1, gas flow rate to 400 mL/min and synthesis time to 45 min.
In order to investigate which catalytic system gave optimum yields, reaction vessel was charged
with catalytic amounts (25, 50 and 100 mg/mL) of respective ferrocene and cobaltocene dissolved in
toluene (Sigma-Aldrich Corporation, St Louis, MO, USA), which also served as the carbon source for
carbon nanotube growth.
3.2. Design and Optimization of Formulations Using a Design Strategy
A three-factor Box-Behnken experimental design (BBD) was generated using Minitab® V15
statistical software (Minitab® Inc., State College, PA, USA) to determine the optimal pyrolysis
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conditions for the synthesis of vertically aligned MWCNTs. The variables employed in the experimental
design were synthesis time, synthesis temperature and gas flow rate. The lower and upper limits for
the synthesis time were 30 min and 60 min, respectively. The synthesis temperature limits were 650 ◦C
and 950 ◦C and that of gas flow rates were 100 and 600 mL/min. The formulation variables were
evaluated for their effect on the yield, length, external diameter and internal diameter of MWCNTs on
both the quartz reactor tube and silicon wafer.
3.3. Functionalization of MWCNTs
The H2SO4:HNO3 functionalized MWCNTs were resuspended in SOCl2: DMF solution (20:1)
and refluxed at 70 ◦C under N2 for 24 h (Scheme 1). The product was centrifuged at 5000 rpm for
20 min (Eppendorf Centrifuge, Eppendorf, Hamburg, Germany) and the precipitates washed with
tetrahydrofuran (THF) at 5000 rpm for 20 min until the supernatant was crystal clear. The acylated carbon
nanotubes (COCl-MWCNTs) were then dried in a vacuum oven at 70 ◦C for 24 h (Trade Raypa Espinar,
Barcelona, Spain) [27].
Scheme 1. Schematic illustration showing the preparation of PEG-MWCNTs.
DSPE PEG5000-4-arm (PEG-amine) was synthesised by reacting one equivalent DSPE
PEG5000-amine (Nanocs Inc., New York, NY, USA) with 5 eq succinic anhydride in dichloromethane
(Sigma Aldrich Corporation, St. Louis, MO, USA). The reaction was stirred at an ambient temperature
for 24 h and evaporated to dryness. The product was reconstituted in deionised water and dialysed
against water in a SnakeSkin dialysis tubing (Pierce-MWCO 3.5 kDa, Thermo Scientific, Waltham,
MA, USA) for two days at a neutral pH. Dialysis tubing content was lyophilized in a Virtis Freeze
Dryer (Gardiner, NY, USA) for 24 h. Then 1.5 eq dicyclohexylcarbodiimide (DCC) was mixed with 2 eq
hydroxybenzotriazole (HOBt) in dichloromethane (DCM) purchased from Sigma-Aldrich Corporation
(St. Louis, MO, USA). The mixture was added to the lyophilised DSPE PEG5000-COOH and reacted at
room temperature for an hour. The 4 eq of 4-arm PEG-amine (Nanocs Inc., New York, NY, USA) was
reacted with DSPE PEG5000-COOH in DCM for two days. The product was evaporated to dryness and
reconstituted in deionised water and stirred for an hour at ambient temperature and filtered through
0.22 µm filter [28].
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Acylated MWCNTs (0.2 mg/mL) were sonicated with 0.2 mM DSPE PEG5000-4-arm-(PEG-amine)
for 1 h. The product was centrifuged at 240,000× g for 6 h (Beckman Coulter, Centrofriger-BL11,
P-Selecta, Abrera, Spain) and supernatant was collected for characterization and drug release studies
(Scheme 1).
3.4. Morphological and Molecular Spectroscopic Evaluation of the MWCNTs
MWCNTs were coated with palladium-gold using sputter coater (Emitech K550X, Emitech Ltd.,
Kent, England) for 4 min at 25 mA and 2 × 10−1 mbar and scanned in FEI Nova NanoLab
600 FEG-SEM/FIB (FEI Company, Hillsboro, OR, USA) to determine their morphology and size.
SEM-EDX analysis was employed to confirm the elemental composition. TEM samples were dispersed
in ethanol, ultrasonicated for 10 min (20 kHz sonicator, VibraCell, Sonics and Materials, Inc., Danbury,
CT, USA), loaded on a copper grids, dried and loaded into FEI Tecnai T12 TEM operating at 120 kV
for scanning and data processed using ImageJ software (National Institutes of Health, Bethesda,
MD, USA).
In order to determine the G and D bands and the effect of functionalization, PEGylated and
non-PEGylated MWCNTs were analysed using Raman Micro200 (Perkin Elmer, Beaconsfield, UK).
Spectra were collected using laser beam of 785 nm wavelength with maximum output of 250 mW
from 200 to 2500 cm−1 at 4 cm−1 resolution. KBr was mixed with MWCNTs, ground to fine
particles, loaded on KBr die and pressed at 4-ton pressure under vacuum for 15 min with KBr
press (ICL, International Crystal Labs, Garfield, NJ, USA) for molecular and vibrational transitions
determination of MWCNTs. The pellet was scanned with Perkin Elmer Spectrum 2000 FTIR
spectrometer (PerkinElmer Spectrum 100, Llantrisant, Wales, UK) at a resolution of 4 cm−1 with
10 accumulations with wavenumbers ranging from 4000 to 400 cm−1. MWCNTs were prepared for 1H
NMR by dispersing 10 mg of Dex, PEG-MWCNTs and Dex-PEG-MWCNTs in 0.4 mL deuterated water,
deuterated methanol and deuterated water, respectively. Samples were ultrasonicated for 2 min and
analysed with 500 MHz Avance III spectrometer (Bruker Corporation, Billerica, MA, USA).
3.5. Thermogravimetric and Porositometric Analyses of MWCNTs
Thermal stability of MWCNTs were determined using a thermogravimetric analyzer (PerkinElmer
TGA 4000, Llantrisant, Wales, UK). MWCNTs samples were heated from 30 ◦C to 950 ◦C under nitrogen
gas purging environment at a constant flow rate of 20 mL/min and temperature ramp of 10 ◦C/min.
Thermograms were generated as percentage weight loss vs. temperature and processed using PyrisTM
software (PerkinElmer, Llantrisant, Wales, UK).
A porositometric analyzer (Micromeritics, ASAP 2020, Norcross, GA, USA) was employed to
determine the porositometric properties of the pristine and functionalized MWCNTs. Sample was
loaded in a sample tube, degassed and analysed by the Brunauer-Emmett-Teller (BET) N2 gas
adsorption method at 77 K.
3.6. Particle Size, Zeta Potential, Crystallinity and Elemental Composition of MWCNTs
The 5 M HCl functionalized MWCNTs were suspended in deionized water at a concentration of
0.2 mg/mL, ultrasonicated for 2 h and measurements of particle size distributions and zeta potential
were obtained using a ZetaSizer NanoZS (Malvern Instruments, Malvern, UK) instrument equipped
with non-invasive backscatter technology set at a fixed angle of 173◦ and a light source with wavelength
of 532 nm.
X-ray diffraction (XRD) patterns of the MWCNTs were examined on X-ray diffractometer (Philips,
PANalytical X’pert PRO, X-ray diffraction system) at 40 kV and 40 mA with Cu Kα radiation (1.54060)
equipped with K-beta filter. Each sample was scanned for 2 h because of high iron content in MWCNTs
and the raw data processed with High Score Plus software (Malvern Panalytical Ltd., Malvern, UK).
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3.7. Dex and Dex-PEG-MWCNTs Preparations and Drug Release Studies
Following 24 h reaction, Dex-MWCNTs were centrifuged at 5000 rpm for 10 min and dried in
a vacuum oven for 24 h at room temperature. The centrifugation procedure was repeated thrice.
Dex was also reacted with PEG-MWCNTs for 24 h, centrifuged and the supernatant collected for
characterisation and drug release studies.
Dex-MWCNTs and Dex-PEG-MWCNTs were dispersed in 10 mL of 0.1 M phosphate buffered
saline (PBS) and dialysis performed against 200 mL PBS buffer with pH 7.4, 6.5 and 5.5 respectively in
an orbital shaker (YIHDER, Taiwan) at 37 ◦C with 30 rpm speed. Collection of 3 mL of the PBS buffer
was done at various time intervals from 0 to 12 h. The sink conditions were maintained.
The λmax of dexamethasone was determined using UV-VIS (Shimadzu Corporation, Kyoto, Japan)
and was found to be 242 nm. Standard curve of Dex was then created using different concentrations
and was used to determine concentrations in 3 mL aliquots of PBS buffer collected at various time
intervals during a 12 h dialysis of the Dex-CNT and Dex-PEG-CNT constructs.
3.8. Cytotoxicity Evaluation of VA-MWCNTs
PC-12 cell lines were grown in RPMI1640 medium supplemented with 5% fetal bovine serum and
10% horse serum in an incubator at 37 ◦C and 5% CO2. A mixture of 1% penicillin and streptomycin
solution was added to the culture medium to prevent bacterial contamination. In each well of
96 well plate, 6 × 104 cells were added and incubated for 24 h with various concentrations (20, 200,
2000 and 20,000 µg/mL of each formulation (free Dex, equivalent Dex concentration coupled to
PEGylated MWNT and sulfonitric acid treated MWCNTs. Controls (PC-12 cells not treated with any
of the formulations-zero concentration group) for each formulation were also included in this study
for comparison. A required amount of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium
Bromide) was added to each well and further incubated for 4 h. Solubilization solution was added to
solubilize formazan crystals and the absorbance read at 570 nm using Multilabel Reader (Victor X3,
Perkin Elmer, Waltham, MA, USA).
4. Conclusions
Vertically aligned MWCNTs were successfully synthesised using the chemical vapor deposition
technique following optimisation of the synthesis parameters such as time, temperature, location of
substrate in the reactor, catalyst and gas flow rates. Carbon nanotubes were successfully purified
and functionalized for dexamethasone loading. PEGylation enhanced the release of dexamethasone
from the VA-MWCNTs. Functionalized carbon nanotubes had a very low cytotoxic effect in cells.
Based on the above findings, functionalized VA-MWCNTs have a potential for sustained delivery of
dexamethasone for an extended period to the diseased site. More work is under way for targeting
ischemic sites using atrial natriuretic peptide antibody in stroke induced rats.
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